Home Healthcare Medical Equipment Cell Line Development Market to 2027

Cell Line Development Market to 2027

Publisher: The Insight Partners
Publication Date: January, 2020
Healthcare / Medical Equipment
Pages: 165
Delivery Format: PDF

Global Analysis and Forecasts By Type (Primary Cell Line, Hybridomas, Continuous Cell Lines, and Recombinant Cell Line); By Product (Equipment and Media & Reagent); Application (Drug Discovery, Bio production and Tissue Engineering); and Geography

Report Features
Table of Contents
Pricing
Methodology
Request Sample
Compare Offers
Make an Offer

The global cell line development market is anticipated to reach US$ 11,161.35 Mn in 2027 from US$ 3,694.87 Mn in 2018. The cell line development market is expected to grow with a CAGR of 13.2% from 2019-2027.
Driving factors are increasing the adoption of regenerative medicines, rising prevalence of cancer across the globe, and increasing investments in R&D by pharmaceutical and biotechnology companies. However, risks associated with cell line contamination is expected to hamper the market during the forecast period.

The cell line is established cell culture, which gets increased numerous times when supplied with the growth medium and space for growth. Different cell lines can be made from different cells. The cell line plays a vital role in the study of cytology. The cell line enables stepwise alterations in the structure, physiology, and genetic makeup of cells under a customized environment.

The global cell line development market is bifurcated into type, product, and application. Based on type, the cell line development market is segmented into a primary cell line, hybridomas, continuous cell lines, and recombinant cell line. Based on product, the cell line development market is segmented into equipment, media and reagent. On the basis of application, the cell line development market is bifurcated into drug discovery, bioproduction, and tissue engineering. In 2018, the bioproduction segment held the largest share of the market. However, the drug discovery segment is expected to register the highest CAGR in the market during the forecast period.

Some of the essential primary and secondary sources included in the report are the Food and Drug Administration (FDA), World Health Organization (WHO), American Cancer Society, National Institute of Cancer Prevention and Research (NICPR), Deutsche Forschungsgemeinschaft (DFG), Defense Advanced Research Projects Agency (DARPA), Centers for Disease Control and Prevention, and others.

Reasons to buy this report:
• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the cell line development market.

• Highlights key business priorities in order to assist companies to realign their business strategies.

• The key findings and recommendations highlight crucial progressive industry trends in the global cell line development market, thereby allowing players across the value chain to develop effective long-term strategies.

• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

• Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Select Plan

1 User License $4,550

Site License License $6,550

Are you looking for a Consultant?

Email Us

Get a Quote

Offer Amount (Per user license)	Retail price (Per user license)
$ .00	$4,550

Cell Line Development Market to 2027

Are you looking for a Consultant?

Customers Who Viewed This Item Also Viewed